Right place right time: the role of immunotherapy in patients with locally advanced gastric/gastroesophageal junction adenocarcinoma
Abigail Fong, Dani Castillo, Pranati Shah, Sophia Guzman, Gagandeep Brar · 2025
Read Right place right time: the role of immunotherapy in patients with locally advanced gastric/gastroesophageal junction adenocarcinoma by Abigail Fong, Dani Castillo, Pranati Shah, Sophia Guzman, Gagandeep Brar (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12780630.txt.
Description
Abigail Fong and four co-authors wrote a 2025 review on the role of immune therapy in stomach cancer and cancer at the joint of the stomach and food pipe. The work looks at cases where the cancer has grown locally but has not spread far. It sets out how drug treatment given around surgery became the norm for these patients.
The review traces two large trials that set the current drug plan, then turns to newer care that adds immune drugs. One trial added a drug called durvalumab to the standard drug plan and found that patients lived longer without the cancer coming back. The authors also look at a phase 2 study that added a second immune drug before surgery. Readers get a clear view of how care for this cancer is changing and what still needs study.
Catalog record
| CREATOR | Abigail Fong, Dani Castillo, Pranati Shah, Sophia Guzman, Gagandeep Brar |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |